Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

IFS vs. SOFI: Which Stock Is the Better Value Option?
IFS vs. SOFI: Which Stock Is the Better Value Option?

Investors with an interest in Financial - Miscellaneous Services stocks have likely encountered both Intercorp Financial Services Inc. (IFS) and SoFi Technologies, Inc. (SOFI). But which of these

BLBD or TSLA: Which Is the Better Value Stock Right Now?
BLBD or TSLA: Which Is the Better Value Stock Right Now?

Investors with an interest in Automotive - Domestic stocks have likely encountered both Blue Bird (BLBD) and Tesla (TSLA). But which of these two stocks presents investors with the better value

KMDA or ARGX: Which Is the Better Value Stock Right Now?
KMDA or ARGX: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Kamada (KMDA) and argenex SE (ARGX). But which of these two companies is the best

GRC vs. TRMB: Which Stock Is the Better Value Option?
GRC vs. TRMB: Which Stock Is the Better Value Option?

Investors looking for stocks in the Manufacturing - General Industrial sector might want to consider either Gorman-Rupp (GRC) or Trimble Navigation (TRMB). But which of these two companies is the

FHI or CNS: Which Is the Better Value Stock Right Now?
FHI or CNS: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Financial - Investment Management sector might want to consider either Federated Hermes (FHI) or Cohen & Steers Inc (CNS). But which of these two companies is the

G or DT: Which Is the Better Value Stock Right Now?
G or DT: Which Is the Better Value Stock Right Now?

Investors with an interest in Computers - IT Services stocks have likely encountered both Genpact (G) and Dynatrace (DT). But which of these two stocks offers value investors a better bang for their

Is NIO Stock Worth Buying Ahead of Q2 Earnings Release?
Is NIO Stock Worth Buying Ahead of Q2 Earnings Release?

China-based EV company NIO Inc. NIO is slated to release second-quarter 2025 results tomorrow, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at a

HMY's FY25 Earnings and Sales Rise Y/Y, Production Decreases
HMY's FY25 Earnings and Sales Rise Y/Y, Production Decreases

Harmony Gold Mining Company Limited HMY reported adjusted earnings of $1.29 per share in fiscal 2025 (ended June 30, 2025), up 30% from adjusted earnings of 99 cents recorded a year ago.

In fiscal

Visa's Future in the Stablecoin Era: Friend, Foe, or Frenemy?
Visa's Future in the Stablecoin Era: Friend, Foe, or Frenemy?

For Visa Inc. V, whose “cash cow” interchange revenues hinge on card-based transactions, the surge of stablecoins represents both a looming threat and a potential growth lever. The payments

Alibaba vs. Amazon: Which E-Commerce Titan Has More Upside Potential?
Alibaba vs. Amazon: Which E-Commerce Titan Has More Upside Potential?

Two of the world's most influential e-commerce and cloud computing giants continue to shape the digital landscape, albeit from different hemispheres. Alibaba Group BABA recently reported revenues of

CCL Trades Near 52-Week High: Harvest Gains or Stay Invested?
CCL Trades Near 52-Week High: Harvest Gains or Stay Invested?

Carnival Corporation & plc CCL shares have been performing well. The stock is currently trading near its 52-week high of $32.77 (touched on Thursday, Aug. 28).In the past three months, CCL stock has

3 Tariff-Proof Retailers Making New All-time Highs
3 Tariff-Proof Retailers Making New All-time Highs

American importers are facing the highest average tariff rates in nearly 100 years following President Trump’s India tariff bump, and businesses are quickly coming to terms with a difficult

Why Is Berkshire Hathaway B (BRK.B) Up 6.4% Since Last Earnings Report?
Why Is Berkshire Hathaway B (BRK.B) Up 6.4% Since Last Earnings Report?

It has been about a month since the last earnings report for Berkshire Hathaway B (BRK.B). Shares have added about 6.4% in that time frame, outperforming the S&P 500.

But investors have to be

MSFT Challenges GPT-5 With New AI Models: What's Next for Investors?
MSFT Challenges GPT-5 With New AI Models: What's Next for Investors?

Microsoft MSFT faces a new catalyst as the tech giant unveiled its first proprietary AI models, marking a strategic shift toward reducing dependence on external AI providers like OpenAI’s GPT-5. The

Here's Why You Should Give Schneider National Stock a Miss Now
Here's Why You Should Give Schneider National Stock a Miss Now

Schneider National, Inc. SNDR is grappling with increased cost pressure due to supply-chain disruptions and inflation. The soft freight market condition is also a major headwind, hurting the

PLL Closes Merger Deal With Sayona to Form Leading Lithium Producer
PLL Closes Merger Deal With Sayona to Form Leading Lithium Producer

Piedmont Lithium Inc. PLL announced that it completed its previously stated merger with Sayona Mining Limited to form a combined company named Elevra Lithium. This merger is expected to boost

Can Affirm Card Be the Next Evolution of Consumer Payments?
Can Affirm Card Be the Next Evolution of Consumer Payments?

Affirm Holdings, Inc. AFRM, a well-known player in the Buy Now, Pay Later (BNPL) space, is making a bold move with its Affirm Card, marking the next chapter in consumer payments. This card is

Procter & Gamble vs. Colgate: Which Household Staple Is a Better Pick?
Procter & Gamble vs. Colgate: Which Household Staple Is a Better Pick?

In the world of everyday essentials, The Procter & Gamble Company PG and Colgate-Palmolive Company CL have carved out powerful, though distinctly different, empires. Both companies dominate

Samsara Set to Report Q2 Earnings: What's in Store for the Stock?
Samsara Set to Report Q2 Earnings: What's in Store for the Stock?

Samsara Inc. IOT is scheduled to report second-quarter fiscal 2026 results on Sept. 4.

For the second quarter of fiscal 2026, management expects non-GAAP earnings per share between 6 cents and 7

lululemon's Q2 Earnings Echo Tariff & Cost Headwinds: Buy Now or Sell?
lululemon's Q2 Earnings Echo Tariff & Cost Headwinds: Buy Now or Sell?

lululemon athletica inc. LULU is likely to witness top-line growth when it reports second-quarter fiscal 2025 results on Sept. 4, after market close. The Zacks Consensus Estimate for fiscal

Is Target's Digital Ecosystem Becoming a Major Profit Engine?
Is Target's Digital Ecosystem Becoming a Major Profit Engine?

Target Corporation TGT delivered renewed strength in its digital channel during the second quarter of fiscal 2025, with comparable digital sales rising 4.3% year over year. The gains were led by

Annaly Jumps 20.6% in a Year: How to Approach the Stock Now?
Annaly Jumps 20.6% in a Year: How to Approach the Stock Now?

Over the past year, Annaly Capital Management NLY shares have gained 20.6%, outperforming the industry’s 7.1% rise. It has also outperformed its peers, AGNC Investment AGNC and Arbor Realty Trust AB

HPE Set to Report Q3 Earnings: What's in Store for the Stock?
HPE Set to Report Q3 Earnings: What's in Store for the Stock?

Hewlett Packard Enterprise HPE is scheduled to report third-quarter fiscal 2025 results on Sept. 3.For the third quarter of fiscal 2025, management expects non-GAAP earnings per share between 30

CCJ Cuts McArthur Rive Output Outlook: Can Cigar Lake Bridge the Gap?
CCJ Cuts McArthur Rive Output Outlook: Can Cigar Lake Bridge the Gap?

Cameco Corporation CCJ has revised its 2025 production outlook, projecting a 19% drop in its share of output from the McArthur River mine compared with its previous expectation. This shortfall is

NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?

Novo Nordisk NVO announced data from a head-to-head study evaluating the risk of major adverse cardiovascular events with Wegovy compared with Eli Lilly’s LLY tirzepatide in patients with overweight